Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075451 · ClinicalTrials.gov registry record
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 41
- Enrollment target
NCT01075451 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 41 participants.
The verdict
NCT01075451 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this investigation is to study the relationships between antimicrobial stewardship program efforts, antimicrobial drug use, and infection control efforts to the incidence rates of hospital acquired infections with Staphylococcus aureus in a sample of US academic medical center hospitals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01075451
The ClinicalTrials.gov registry entry for NCT01075451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01075451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01075451 about?
NCT01075451 is a clinical study titled "Antimicrobial Drug Use and Resistant Staphylococcus Aureus". The purpose of this investigation is to study the relationships between antimicrobial stewardship program efforts, antimicrobial drug use, and infection control efforts to the incidence rates of hospital acquired infections with Staphylococcus aureus in a sample of US academic medical center hospita...
What is the current status of trial NCT01075451?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2010-01. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01075451?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.